a double-blind , crossover trial was carried out to assess the clinical efficacy of 3.6 g aspirin , 1200 mg azapropazone and the two drugs together in 24 adult patients with classical or definite rheumatoid disease .
C0004057
aspirin
C0003873
rheumatoid disease